- The Stock Scoop
- Posts
- The Stock Scoop ⚡ Health is wealth
Welcome back to The Stock Scoop, the community with fresh takes on the latest market moves, exclusive CEO interviews and insights that help investors stay one step ahead. If you're new here - welcome. You’ve joined a growing group that knows staying informed is the first step to investing smarter.
As the new year kicks off, it’s worth remembering that the best long-term investment most of us make is in our own health. Markets compound, but so do habits. The same patience, discipline and long-term thinking that drives good investing applies just as much outside the portfolio. Health was at the forefront for me last year as my father died from cancer after a 10 year battle, I joined the Board of medical device company OncoSil (ASX:OSL) and watched the global medical industry explode with demand.
Healthcare momentum builds
In the last year Eli Lilly And Co. (NYSE:LLY) became the first healthcare company to reach US$1 trillion in market value and over the last six months the NASDAQ Biotech Index has soared 36%, the highest-performing major index in the last half year. Inspired by this growing momentum The Stock Network brought together leaders across the listed healthcare space last month for our ASX Gems Healthcare spotlight. Watch the full livestream here
Watch Bell Potter's Analyst John Hester discuss Mesoblast (ASX:MSB), Pro Medicus (ASX:PME), Telix Pharmaceuticals (ASX:TLX), Clarity Pharmaceuticals (ASX:CU6), Immutep (ASX:IMM) and 4DMedical (ASX:4DX).
Watch The Armchair Analyst Jason Segal discuss Eli Lilly and Company (NYSE:LLY), 4DMedical (ASX:4DX), Starpharma Holdings (ASX:SPL), Actinogen Medical (ASX:ACW), Neuren Pharmaceuticals (ASX:NEU), Mesoblast (ASX:MSB), Oneview Healthcare (ASX:ONE) and Cynata Therapeutics (ASX:CYP).
Share market outlook 2026
With AI valuations soaring and geopolitics fracturing, how are stock market investors preparing for the year ahead? I spoke with The Australian alongside Australian Shareholders' Association. Key themes discussed in the article include:
The AI boom driving market uncertainty and opportunity
How Trump's policies are reshaping global trade
Geopolitical tensions elevating investment risk
Do you have a stock story to share?
If you've got a stock story I'd love to hear about it and share with our investor distribution network that has just ticked past 300,000+. Our media network has also strengthened with a Meltwater partnership across news, online, broadcast, social and forums. Our social engagement is growing exponentially and the inbound investors interest I'm receiving is at record highs.
To your health & wealth in 2026
Given your body is the only asset you’re guaranteed to hold for life, I wish you the health, energy and clarity to make the most of every opportunity ahead. And if one of those opportunities involves communicating with investors - please reach out, I'm excited to share the best stocks stories in the year ahead.
To your investing,
 |  |
      |       |       |
Contact me for exclusive opportunities to participate
If you are a listed company executive or investor
Disclaimer
The material contained in this email is general in nature only and does not constitute personal financial or legal advice. None of our material should be regarded as advice and you should not rely on any of the content of this post without first obtaining specific professional advice.
We give no warranty to the accuracy, reliability or completeness of information that is contained in this email and exclude liability for any loss.
This email may contain views and opinions which are those of the authors and do not necessarily reflect the official policy or position of any other author, agency, organisation, employer or company. We are not liable for any comment published by users and reserve the right to delete any comment for any reason whatsoever.
We have commercial relationships with some of our contributors, and we may receive payment or other benefits from this email.
Please see our full content disclaimer.